1-5 of 5
Elena Oldani, BSc
Close
Sort by
Journal Articles

Short Chemotherapy-Phased Imatinib (IM) Pulses Improve Long-Term Outcome of Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Renato Bassan, MD, Giuseppe Rossi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Emanuele Angelucci, MD, Irene Cavattoni, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Alessandro Levis, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Erika Borlenghi, MD, Elisabetta Terruzzi, MD, Carlo Borghero, MD, Claudio Romani, MD, Orietta Spinelli, BSc, Manuela Tosi, BSc, Elena Oldani, BSc, Tamara Intermesoli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 2029.
https://doi.org/10.1182/blood.V114.22.2029.2029
Published: 2009
Journal Articles

Minimal Residual Disease (MRD)-Oriented Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Results of Northern Italy Leukemia Group Study 09/00.

Renato Bassan, MD, Orietta Spinelli, BSc, Elena Oldani, BSc, Tamara Intermesoli, MD, Manuela Tosi, BSc, Barbara Peruta, BSc, Vittoria Guerini, BSc, Giuseppe Rossi, MD, Enrico Pogliani, MD, Eros Di Bona, MD, Pietro Fabris, MD, Agostino Cortelezzi, MD, Teodoro Chisesi, MD, Emanuele Angelucci, MD, Franco Leoni, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2007) 110 (11): 3497.
https://doi.org/10.1182/blood.V110.11.3497.3497
Published: 2007
Journal Articles

Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL).

Renato Bassan, MD, Orietta Spinelli, BSc, Elena Oldani, BSc, Tamara Intermesoli, MD, Manuela Tosi, BSc, Giuseppe Rossi, MD, Enrico M. Pogliani, MD, Emanuele Angelucci, MD, Pietro Fabris, MD, Giorgio Lambertenghi-Deliliers, MD, Paola Polistena, MD, Eros Di Bona, MD, Fabio Ciceri, MD, Franco Leoni, MD, Claudia Minotto, MD, Daniele Mattei, MD, Maurizio Musso, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2005) 106 (11): 1836.
https://doi.org/10.1182/blood.V106.11.1836.1836
Published: 2005
Journal Articles

The Stage-Modified IPI (MIPI), Histology and a Combined Treatment Influence the Clinical Outcome of 401 Patients with Primary Extranodal Head and Neck B-Cell Lymphomas (PHNBCL) (IELSG 23).

Sergio Cortelazzo, MD, Andrea Rossi, MD, Massimo Federico, MD, Andrea Peveri, MD, Stefano Magrini, MD, Maurizio Martelli, MD, Armando Lopez Guillermo, MD, Elena Oldani, BSc, Alessandro Rambaldi, MD, Fausto Rossini, MD, Enrico M. Pogliani, MD, Emanuele Zucca, MD, Annarita Conconi, MD, Mario Busetto, MD, Gianluca Gaidano, MD, Tiziano Barbui, MD, Franco Cavalli, MD
Journal: Blood
Blood (2005) 106 (11): 927.
https://doi.org/10.1182/blood.V106.11.927.927
Published: 2005
Journal Articles

Bone Marrow BCL2/IgH+ Cells at Diagnosis and Not FCGRIIIA Polymorphism Predict Response in Follicular Non-Hodgkin’s Lymphoma Patients Treated with Sequential CHOP and Rituximab.

Emanuela Carlotti, BSc, Giuseppe A. Palumbo, MD, Elena Oldani, BSc, Sara Acerboni, BSc, Francesco Di Raimondo, MD, Sergio Cortelazzo, MD, Alessandro Pulsoni, MD, Tiziano Barbui, MD, Robert Foa, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2005) 106 (11): 985.
https://doi.org/10.1182/blood.V106.11.985.985
Published: 2005